Skip Navigation


Carcinogenesis Advance Access originally published online on January 23, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary data
Right arrow All Versions of this Article:
25/5/669    most recent
bgh071v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (26)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by King, T. J.
Right arrow Articles by Lampe, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by King, T. J.
Right arrow Articles by Lampe, P. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 25, No. 5, 669-680, May 2004
Carcinogenesis vol.25 no.5 © Oxford University Press 2004; all rights reserved.


ARTICLE

Mice deficient for the gap junction protein Connexin32 exhibit increased radiation-induced tumorigenesis associated with elevated mitogen-activated protein kinase (p44/Erk1, p42/Erk2) activation

Timothy J. King1,2,3 and Paul D. Lampe1,2

1 Cancer Prevention Research Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA and 2 Department of Pathobiology, University of Washington, Seattle, WA 98195, USA

3 To whom correspondence should be addressed Email: tking{at}fhcrc.org

Loss of connexin expression/gap junction intercellular communication (GJIC) has been correlated with decreased growth control and increased tumorigenesis. Studies utilizing Connexin32 (Cx32)-deficient knockout mice have demonstrated that loss of Cx32 increases susceptibility to chemically induced liver tumorigenesis. Here, in addition to dramatically increased liver tumorigenesis, we show that tumor induction utilizing X-ray radiation resulted in a statistically significant increase in overall tumor burden in Cx32-deficient mice compared with wild-type mice due to tumorigenesis in several other tissues (lung, adrenal, lymph and small intestine) even when excluding prevalent liver tumors. Irradiated Cx32-deficient mice were particularly sensitive to liver tumorigenesis (46% incidence compared with 18% in wild-type mice, P = 0.007) demonstrating that Cx32 functions as a hepatic tumor suppressor in response to radiation-associated mutation events. Cx32-deficient mice also exhibited increased lung tumorigenesis (bronchioloalveolar) with an increased progression to carcinoma when compared with wild-type mice. Two Cx32-deficient mice developed an uncommon, invasive medullary adrenal tumor type (pheochromocytoma) not observed in irradiated wild-type mice. Immunohistochemical analysis revealed increased levels of activated mitogen-activated protein kinase (MAPK) (p44/Erk1, p42/Erk2) in Cx32-deficient mouse liver tumors (P = 0.006), lung tumors (P = 0.056) and adrenal tumors (primary and metastases) compared with wild-type counterparts implicating elevated activation of MAPK-interacting pathways in Cx32-deficient tumorigenesis. Interestingly, lung tumors from Cx32-deficient mice also demonstrated decreased p27Kip1 levels compared with wild-type lung tumors (P = 0.05). This study demonstrates that loss of Cx32/GJIC plays a significant role in radiation-induced tumorigenesis of the liver and importantly that Cx32 may also play a role in tumor suppression and/or tumor progression in other tissue types such as lung and adrenal gland. Additionally, this mouse model suggests that MAPK-related pathways may be preferentially activated or conversely that tumors harboring activated MAPK pathways may selectively progress towards more advanced tumor states in the absence of Cx32-mediated GJIC.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
Y. Hirabayashi, B.-I. Yoon, I. Tsuboi, Y. Huo, Y. Kodama, J. Kanno, T. Ott, J. E. Trosko, and T. Inoue
Protective Role of Connexin 32 in Steady-State Hematopoiesis, Regeneration State, and Leukemogenesis
Experimental Biology and Medicine, May 1, 2007; 232(5): 700 - 712.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
I. Plante, D. G. Cyr, and M. Charbonneau
Sexual Dimorphism in the Regulation of Liver Connexin32 Transcription in Hexachlorobenzene-Treated Rats
Toxicol. Sci., March 1, 2007; 96(1): 47 - 57.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. McLachlan, Q. Shao, H.-l. Wang, S. Langlois, and D. W. Laird
Connexins Act as Tumor Suppressors in Three-dimensional Mammary Cell Organoids by Regulating Differentiation and Angiogenesis.
Cancer Res., October 15, 2006; 66(20): 9886 - 9894.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. M. Hix, D. A. Frey, M. D. McLaws, M. Osterlie, S. F. Lockwood, and J. S. Bertram
Inhibition of chemically-induced neoplastic transformation by a novel tetrasodium diphosphate astaxanthin derivative
Carcinogenesis, September 1, 2005; 26(9): 1634 - 1641.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
J. E. Trosko and B. L. Upham
The emperor wears no clothes in the field of carcinogen risk assessment: ignored concepts in cancer risk assessment
Mutagenesis, March 1, 2005; 20(2): 81 - 92.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
J E Trosko
The role of stem cells and cell-cell communication in radiation carcinogenesis: ignored concepts
Br. J. Radiol., January 1, 2005; Supplement_27(1): 132 - 138.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. J. King and P. D. Lampe
The Gap Junction Protein Connexin32 Is a Mouse Lung Tumor Suppressor
Cancer Res., October 15, 2004; 64(20): 7191 - 7196.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.